Hypercell Technologies develops tools to control infectious diseases in animals.
Hypercell Technologies's investors include Plug and Play, SOSV, SOSV SF & NY (Fka IndieBio), Grow-NY.
Hypercell Technologies is headquartered in Atlanta, United States.
Hypercell Technologies develops tools to control infectious diseases in animals.
Hypercell Technologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hypercell Technologies — Funding & Investors." VCBacked, April 2, 2024, https://www.vcbacked.co/company/hypercell-technologies. Accessed September 30, 2026.
VCBacked. (2024). Hypercell Technologies — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/hypercell-technologies
{{cite web |title=Hypercell Technologies — Funding & Investors |url=https://www.vcbacked.co/company/hypercell-technologies |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated